4 Largecap High Margin Fast Revenue Growth Five-Year Winner Stocks to Watch for Future Multibagger Potential: Adani Ports, Torrent Pharma, Laurus Labs and Indian Hotels
- November 11, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Adani Ports Rs 1,942.70. Torrent Pharma Rs 4,780. Laurus Labs Rs 2,454. Indian Hotels Rs 891.65. Market caps from Rs 1.24 lakh crore to Rs 4.47 lakh crore. Data as of 10 Nov 2026.
Quick Answer
Adani Ports, Torrent Pharma, Laurus Labs and Indian Hotels are the 4 picks in this high margin fast revenue growth five-year winner stocks watchlist, with market caps between Rs 1.24 lakh crore and Rs 4.47 lakh crore. Adani Ports stands out for the lowest PE of the group at 34.07, while Torrent Pharma offers the highest return on equity at 25.49%. PE ratios run from 34.07 to 118.73, so compare each one with its industry PE before investing. All figures are as of 10 November 2026.
High margin fast revenue growth five-year winner stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Adani Ports, Torrent Pharma, Laurus Labs and Indian Hotels meet that test, with market caps from Rs 1.24 lakh crore to Rs 4.47 lakh crore and Adani Ports offering the lowest PE of the group at 34.07. Each of these companies has an operating margin of at least 20 per cent, FY26 revenue growth of at least 15 per cent and a five-year share price return of at least 100 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with an operating margin of at least 20 per cent, FY26 revenue growth of at least 15 per cent and a five-year share price return of at least 100 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening high margin fast revenue growth five-year winner stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 10 November 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are High Margin Fast Revenue Growth Five-Year Winner Stocks and Why Do They Attract Multibagger Interest?
High margin fast revenue growth five-year winner stocks are shares of large companies that keep at least twenty paise of operating profit from every rupee of sales, grew sales by fifteen per cent or more in FY26 and have at least doubled their share price over five years. The four here cover pharmaceutical ingredients, pharmaceuticals, ports and hotels.
A rich margin shows pricing strength, fast sales growth shows demand, and a doubled share price shows that the market has rewarded the combination over a long period. Within high margin fast revenue growth five-year winner stocks, the four companies show rising profit. In high margin fast revenue growth five-year winner stocks, each of the four also posted growth in the latest quarter. For high margin fast revenue growth five-year winner stocks, both FY26 and the latest quarter showed growth. Whichever way you read high margin fast revenue growth five-year winner stocks, the common thread is rising profit backed by complete financial data. Investors researching high margin fast revenue growth five-year winner stocks get a fuller picture by reading growth and valuation together. The table below lines up high margin fast revenue growth five-year winner stocks on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use high margin fast revenue growth five-year winner stocks as a starting point for your own research.
High Margin Fast Revenue Growth Five-Year Winner Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 10 November 2026. Adani Ports has the lowest PE of the group at 34.07, while Torrent Pharma posts the highest return on equity at 25.49%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Adani Ports and Special Economic Zone | 1,942.70 | 4,47,027 | 34.07 | 31.83 | 13.32% | 0.66 | 1,292.00 to 1,949.30 |
| Torrent Pharmaceuticals | 4,780 | 1,81,448 | 84.16 | 36.42 | 25.49% | 1.79 | 3,480.60 to 5,250.00 |
| Laurus Labs | 2,454 | 1,29,452 | 118.73 | 36.42 | 16.77% | 0.48 | 864.70 to 2,454.00 |
| Indian Hotels Company | 891.65 | 1,23,580 | 53.52 | 36.77 | 15.97% | 0.22 | 568.70 to 971.00 |
Adani Ports: 26.74% Profit CAGR Since FY22
Adani Ports and Special Economic Zone is India’s largest private port operator, with ports on both coasts and a growing logistics business. It reported FY26 revenue of Rs 40,854.36 crore, up 26.16% year on year, and net profit of Rs 12,782.03 crore, up 15.56%. Net profit has compounded at 26.74% a year since FY22, while revenue has grown 20.55% a year. Operating margin was 64.59% in FY26.
In the June 2026 quarter, revenue rose 23.90% to Rs 11,673.71 crore and net profit grew 10.24% to Rs 3,649.50 crore. The share price has gained 120.27% over five years and 20.67% over the past year. Foreign investors raised their holding from 13.61% in September 2025 to 15.95% in September 2026. The stock trades at a PE of 34.07 against an industry PE of 31.83, with a return on equity of 13.32%.
Torrent Pharma: 28.79% Profit CAGR Since FY22
Torrent Pharmaceuticals makes branded medicines for chronic therapies such as cardiac, gastro-intestinal and central nervous system care in India and overseas. It reported FY26 revenue of Rs 13,886.15 crore, up 20.34% year on year, and net profit of Rs 2,138.18 crore, up 11.87%. Net profit has compounded at 28.79% a year since FY22, while revenue has grown 12.38% a year. Operating margin was 22.70% in FY26.
The stock trades at a PE of 84.16 against an industry PE of 36.42, with a return on equity of 25.49%. In the June 2026 quarter, revenue rose 56.29% to Rs 4,909 crore and net profit grew 3.28% to Rs 566 crore. The share price has gained 200.24% over five years and 32.19% over the past year. Domestic institutions raised their holding from 9.28% in September 2025 to 12.87% in July 2026.
Laurus Labs: Revenue Up 22.01% in FY26
Laurus Labs makes active pharmaceutical ingredients and formulations and offers contract development and manufacturing services. It reported FY26 revenue of Rs 6,867.85 crore, up 22.01% year on year, and net profit of Rs 889.85 crore, up 151.08%. Revenue has compounded at 8.53% a year since FY22. Operating margin was 26.90% in FY26. The debt-to-equity ratio is 0.48.
In the June 2026 quarter, revenue rose 28.83% to Rs 2,035.49 crore and net profit grew 124.73% to Rs 361.99 crore. The share price has gained 221.51% over five years and 137.61% over the past year. Domestic institutions raised their holding from 11.94% in June 2025 to 13.74% in June 2026. The stock trades at a PE of 118.73 against an industry PE of 36.42, with a return on equity of 16.77%.
Indian Hotels: Quarterly Profit Up 22.39%
Indian Hotels Company, part of the Tata Group, runs Taj, SeleQtions, Vivanta and Ginger hotels and resorts. It reported FY26 revenue of Rs 9,971.43 crore, up 16.42% year on year, and net profit of Rs 2,195.14 crore, up 11.93%. Revenue has compounded at 32.74% a year since FY22. Operating margin was 35.53% in FY26. The debt-to-equity ratio is 0.22.
The stock trades at a PE of 53.52 against an industry PE of 36.77, with a return on equity of 15.97%. In the June 2026 quarter, revenue rose 15.09% to Rs 2,419.37 crore and net profit grew 22.39% to Rs 390.93 crore. The share price has gained 670.13% over five years. Domestic institutions raised their holding from 18.52% in June 2025 to 24.59% in June 2026.
High Margin Fast Revenue Growth Five-Year Winner Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these high margin fast revenue growth five-year winner stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | Latest Quarter Revenue Growth | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Adani Ports | 40,854.36 | 12,782.03 | 26.16% | 20.55% | 23.90% | 65.67% |
| Torrent Pharma | 13,886.15 | 2,138.18 | 20.34% | 12.38% | 56.29% | 33.73% |
| Laurus Labs | 6,867.85 | 889.85 | 22.01% | 8.53% | 28.83% | 31.95% |
| Indian Hotels | 9,971.43 | 2,195.14 | 16.42% | 32.74% | 15.09% | 32.19% |
Institutional Holding in Adani Ports, Torrent Pharma, Laurus Labs and Indian Hotels
Institutional holding shows who is backing these high margin fast revenue growth five-year winner stocks alongside the promoter. The table uses the latest reported quarter for each. Indian Hotels has the deepest institutional backing, with FII and DII together holding 46.30% as of June 2026. Domestic institutions increased their holding over the past year in Torrent Pharma (from 9.28% to 12.87%), Laurus Labs (from 11.94% to 13.74%) and Indian Hotels (from 18.52% to 24.59%). Keeping an eye on the Nifty 100 alongside this list shows whether these shares are moving with the wider market.
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Adani Ports | 66.03% | 15.95% | 13.25% | 4.77% | September 2026 |
| Torrent Pharma | 60.78% | 17.97% | 12.87% | 8.38% | July 2026 |
| Laurus Labs | 27.47% | 28.00% | 13.74% | 30.78% | June 2026 |
| Indian Hotels | 38.12% | 21.71% | 24.59% | 15.58% | June 2026 |
Risks to Weigh in High Margin Fast Revenue Growth Five-Year Winner Stocks
Being careful with high margin fast revenue growth five-year winner stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Laurus Labs trades at a PE of 118.73 against an industry PE of 36.42, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between High Margin Fast Revenue Growth Five-Year Winner Stocks
Picking from high margin fast revenue growth five-year winner stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (31.83 to 36.77) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Adani Ports, Torrent Pharma, Laurus Labs and Indian Hotels live prices.
Conclusion
Among high margin fast revenue growth five-year winner stocks, Adani Ports stands out for the lowest PE of the group at 34.07, Torrent Pharma for the highest return on equity at 25.49%, Laurus Labs for the strongest latest-quarter profit growth at 124.73% and Indian Hotels for the biggest five-year price gain at 670.13%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing high margin fast revenue growth five-year winner stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on High Margin Fast Revenue Growth Five-Year Winner Stocks to Watch
Which are the best high margin fast revenue growth five-year winner stocks to watch for multibagger potential?
Ans. Adani Ports, Torrent Pharma, Laurus Labs and Indian Hotels are the 4 names this list highlights, with market caps of Rs 4,47,027 crore, Rs 1,81,448 crore, Rs 1,29,452 crore and Rs 1,23,580 crore respectively. Adani Ports is notable for the lowest PE of the group at 34.07. Torrent Pharma stands out for the highest return on equity at 25.49%. Laurus Labs offers the strongest latest-quarter profit growth at 124.73%. Indian Hotels brings the biggest five-year price gain at 670.13%. These are watchlist names for high margin fast revenue growth five-year winner stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Torrent Pharma a good stock for long-term investors?
Ans. Torrent Pharma has a return on equity of 25.49%, a PE of 84.16 against an industry PE of 36.42 and a market cap of Rs 1,81,448 crore. Net profit has compounded at 28.79% a year since FY22, and FY26 revenue rose 20.34% while June 2026 quarter net profit grew 3.28%. Long-term returns in high margin fast revenue growth five-year winner stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Adani Ports become a multibagger from here?
Ans. Adani Ports has already gained 120.27% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in high margin fast revenue growth five-year winner stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 26.74% a year since FY22, and FY26 revenue rose 26.16%. At a PE of 34.07 against an industry PE of 31.83, valuation should be checked against that growth before investing.
What is the market cap of Adani Ports, Torrent Pharma, Laurus Labs and Indian Hotels?
Ans. As of 10 November 2026, Adani Ports has a market cap of Rs 4,47,027 crore, Torrent Pharma has a market cap of Rs 1,81,448 crore, Laurus Labs has a market cap of Rs 1,29,452 crore and Indian Hotels has a market cap of Rs 1,23,580 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on high margin fast revenue growth five-year winner stocks.
What are the risks of investing in high margin fast revenue growth five-year winner stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Laurus Labs trades at a PE of 118.73 against an industry PE of 36.42, so earnings growth needs to hold up.
Why is Laurus Labs trading at a PE of 118.73?
Ans. Laurus Labs’ PE of 118.73 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 16.77%, latest-quarter profit growth of 124.73% and FY26 revenue growth of 22.01%, which also means the stock is more sensitive if growth slows. Investors in high margin fast revenue growth five-year winner stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Adani Ports, Torrent Pharma, Laurus Labs and Indian Hotels?
Ans. As of the latest reported quarter, FII and DII together hold 29.20% of Adani Ports (15.95% and 13.25%), 30.84% of Torrent Pharma (17.97% and 12.87%), 41.74% of Laurus Labs (28.00% and 13.74%) and 46.30% of Indian Hotels (21.71% and 24.59%). Rising institutional holding is a useful signal in high margin fast revenue growth five-year winner stocks, though it should be read with earnings trends rather than on its own.
